Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Mayer

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|April 1, 2009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysisBengt C Fellström, Alan G Jardine, Roland E Schmieder, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
European Journal of Clinical Investigation|April 24, 2012
Implementation of proteomic biomarkers: making it workHarald Mischak, John P A Ioannidis, Angel Argiles, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Hypertension (Dallas, Tex. : 1979)|February 15, 2021
Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?Antonia Vlahou, Dara Hallinan, Rolf Apweiler, et al.
Wiener Klinische Wochenschrift|December 4, 2019
[Austrian Consensus on High Blood Pressure 2019]Thomas Weber, Klaus Arbeiter, Florian Ardelt, et al.
Kidney International Reports|October 18, 2023
Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD CohortsMark Canney, Dilshani Induruwage, Mila Tang, et al.
Journal of the American Society of Nephrology : JASN|October 21, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with PodocytopathiesPhilipp Gauckler, Anna Matyjek, Seleni Kapsia, et al.
Orphanet Journal of Rare Diseases|November 10, 2019
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathyNóra Garam, Zoltán Prohászka, Ágnes Szilágyi, et al.
Clinical Kidney Journal|April 17, 2020
Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysisNóra Garam, Zoltán Prohászka, Ágnes Szilágyi, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|April 1, 2009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysisBengt C Fellström, Alan G Jardine, Roland E Schmieder, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
European Journal of Clinical Investigation|April 24, 2012
Implementation of proteomic biomarkers: making it workHarald Mischak, John P A Ioannidis, Angel Argiles, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Hypertension (Dallas, Tex. : 1979)|February 15, 2021
Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?Antonia Vlahou, Dara Hallinan, Rolf Apweiler, et al.
Wiener Klinische Wochenschrift|December 4, 2019
[Austrian Consensus on High Blood Pressure 2019]Thomas Weber, Klaus Arbeiter, Florian Ardelt, et al.
Kidney International Reports|October 18, 2023
Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD CohortsMark Canney, Dilshani Induruwage, Mila Tang, et al.
Journal of the American Society of Nephrology : JASN|October 21, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with PodocytopathiesPhilipp Gauckler, Anna Matyjek, Seleni Kapsia, et al.
Orphanet Journal of Rare Diseases|November 10, 2019
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathyNóra Garam, Zoltán Prohászka, Ágnes Szilágyi, et al.
Clinical Kidney Journal|April 17, 2020
Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysisNóra Garam, Zoltán Prohászka, Ágnes Szilágyi, et al.
Pageof 25